The State of Texas Attorney General Files Lawsuit Against Acetaminophen Manufacturers Over Autism Spectrum Assertions

Courtroom Proceedings
Ken Paxton, who supports former President Trump who is running for the United States Senate, accused pharmaceutical manufacturers of hiding potential dangers of Tylenol

Texas Attorney General Ken Paxton is suing the producers of Tylenol, claiming the corporations withheld potential risks that the drug posed to pediatric cognitive development.

The lawsuit follows a month after Donald Trump advocated an unsubstantiated connection between consuming Tylenol - also known as acetaminophen - while pregnant and autism spectrum disorder in young ones.

Paxton is taking legal action against Johnson & Johnson, which previously sold the drug, the exclusive pain medication suggested for expectant mothers, and the current manufacturer, which now manufacturers it.

In a statement, he claimed they "misled consumers by profiting off of pain and pushing pills ignoring the dangers."

The manufacturer says there is no credible evidence linking Tylenol to autism spectrum disorder.

"These companies lied for decades, intentionally threatening numerous people to increase profits," Paxton, from the Republican party, declared.

Kenvue stated officially that it was "deeply concerned by the perpetuation of misinformation on the reliability of acetaminophen and the possible consequences that could have on the welfare of American women and children."

On its website, the company also said it had "continuously evaluated the pertinent research and there is insufficient valid information that demonstrates a verified association between consuming paracetamol and autism."

Organizations representing physicians and health professionals concur.

ACOG has said paracetamol - the primary component in acetaminophen - is one of the few options for women during pregnancy to treat discomfort and fever, which can pose serious health risks if ignored.

"In more than two decades of studies on the consumption of paracetamol in pregnancy, not a single reputable study has conclusively proven that the consumption of paracetamol in any stage of pregnancy leads to brain development issues in children," the organization said.

The court filing mentions current declarations from the previous government in claiming the medication is potentially dangerous.

Recently, the former president generated worry from health experts when he instructed expectant mothers to "resist strongly" not to use acetaminophen when ill.

Federal regulators then published an announcement that medical professionals should think about restricting the consumption of acetaminophen, while also mentioning that "a causal relationship" between the medication and autism in children has not been established.

Health Secretary RFK Jr, who manages the Food and Drug Administration, had pledged in April to undertake "a massive testing and research effort" that would identify the cause of autism in a limited time.

But authorities warned that finding a single cause of autism - thought by researchers to be the consequence of a complex mix of genetic and external influences - would be difficult.

Autism is a category of permanent neurological difference and disability that impacts how individuals perceive and relate to the environment, and is diagnosed using physician assessments.

In his legal document, Paxton - a Trump ally who is campaigning for US Senate - claims the manufacturer and J&J "deliberately disregarded and tried to quiet the science" around acetaminophen and autism spectrum disorder.

The case seeks to make the corporations "remove any promotional materials" that asserts Tylenol is secure for pregnant women.

The court case echoes the grievances of a collection of guardians of young ones with autism and ADHD who filed suit against the makers of Tylenol in 2022.

A federal judge rejected the lawsuit, stating investigations from the plaintiffs' authorities was lacking definitive proof.

Elizabeth Alvarez
Elizabeth Alvarez

Elara is a seasoned strategist with over a decade of experience in corporate leadership and military tactics.